Lexeo Therapeutics, Inc. (LXEO)
(Real Time Quote from BATS)
$13.28 USD
+0.14 (1.07%)
Updated May 13, 2024 01:00 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | -0.76 |
EPS Last Quarter | -0.77 |
Last EPS Surprise | -1.32% |
ABR | 1.20 |
Earnings ESP
|
-43.42% |
---|---|
Current Year | -3.04 |
Next Year | -3.04 |
EPS (TTM) | -22.29 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 0.65M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.76 | -0.78 | -3.04 | -3.04 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -1.09 | -1.09 | -4.36 | -4.39 |
High Estimate | -0.52 | -0.53 | -2.33 | -1.96 |
Low Estimate | -1.09 | -1.09 | -4.36 | -4.39 |
Year ago EPS | -8.30 | -12.36 | -12.40 | -3.04 |
Year over Year Growth Est. | 90.84% | 93.69% | 75.48% | -0.06% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.76 | -0.78 | -3.04 | -3.04 |
7 Days Ago | -0.76 | -0.78 | -3.04 | -3.04 |
30 Days Ago | -0.76 | -0.78 | -3.03 | -3.02 |
60 Days Ago | -0.82 | -0.82 | -3.09 | -3.12 |
90 Days Ago | -0.72 | -0.68 | -2.71 | -2.32 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.09 | -1.09 | -4.36 | -4.39 |
Zacks Consensus Estimate | -0.76 | -0.78 | -3.04 | -3.04 |
Earnings ESP | -43.42% | -39.15% | -43.66% | -44.57% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.77 | -0.86 | -12.36 | -8.30 | NA |
Estimate | -0.76 | -0.71 | -0.90 | NA | NA |
Difference | -0.01 | -0.15 | -11.46 | NA | -3.87 |
Surprise | -1.32% | -21.13% | -1,273.33% | NA | -431.93% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more